{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T06:27:20Z","timestamp":1794724040722,"version":"4.9.1"},"reference-count":51,"publisher":"BMJ","issue":"11","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"unspecified","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Fogarty International Center and the National Institute of Alcohol Abuse and Alcoholism of the National Institutes of Health","award":["D43TW011532"],"award-info":[{"award-number":["D43TW011532"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,11,3]]},"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To provide the first national estimate of syphilis prevalence among people who inject drugs (PWID) in Georgia, alongside updated HIV prevalence and associated risk behaviours, and to identify factors associated with infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Cross-sectional Integrated Bio-Behavioural Surveillance Survey conducted in 2022. Respondent-driven sampling was used to recruit PWID. Data were collected through standardised face-to-face interviews using structured questionnaires, and venous blood samples were collected for laboratory testing. HIV was diagnosed by serology, and syphilis was assessed using a two-step algorithm (Rapid Plasma Reagin screening with Treponema pallidum haemagglutination assay confirmation). Logistic regression models were applied to identify correlates of infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>The study was conducted in community settings across seven major cities of Georgia that represent the main urban centres with large PWID populations. Survey implementation was supported by local peer-led and community-based harm reduction organisations with established trust and access to PWID networks, facilitating participant recruitment and ensuring feasibility.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>HIV prevalence was 0.9% and syphilis prevalence 2.1%. Coinfection with HIV and syphilis was observed in 0.2% of participants. HIV infection was significantly associated with longer duration of injection drug use (adjusted OR (aOR) 0.2; 95%\u2009CI 0.5 to 0.9) and lack of access to HIV prevention services (aOR 2.8; 95%\u2009CI 1.1 to 7.8). Syphilis prevalence was significantly lower among PWID who had not had casual or paid sex in the past year (OR 0.06; 95%\u2009CI 0.02 to 0.2). Unsafe sexual behaviours were common: 25.8% reported sex with a casual partner in the past year, 12.3% reported a paid partner, and only around half used condoms consistently with these partners.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Despite a relatively low HIV prevalence, syphilis prevalence among PWID in Georgia highlights ongoing sexual risk behaviours. Current harm reduction programmes primarily address injection-related risks, with limited sexually transmitted infection (STI) prevention efforts. Expanding sexual health interventions within harm reduction services, including STI screening, structured counselling and safe sex education, is essential to reduce STI transmission and improve health outcomes among PWID.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-103983","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T07:50:17Z","timestamp":1764057017000},"page":"e103983","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["HIV and syphilis seroprevalence and related unsafe sexual behaviours among people who inject drugs in Georgia: a cross-sectional study"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0270-607X","authenticated-orcid":false,"given":"Maia","family":"Kajaia","sequence":"first","affiliation":[{"name":"Ivane Javakhishvili Tbilisi State University, Tbilisi, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1614-854X","authenticated-orcid":false,"given":"Mamuka","family":"Djibuti","sequence":"additional","affiliation":[{"name":"Partnership Research Action Health (PRAH), Tbilisi, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7307-0614","authenticated-orcid":false,"given":"Jack A","family":"DeHovitz","sequence":"additional","affiliation":[{"name":"SUNY Downstate Health Sciences University, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Kamkamidze","sequence":"additional","affiliation":[{"name":"Health Research Union (HRU), Tbilisi, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8390-3325","authenticated-orcid":false,"given":"Davit","family":"Baliashvili","sequence":"additional","affiliation":[{"name":"Partnership Research Action Health (PRAH), Tbilisi, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Kochlamazashvili","sequence":"additional","affiliation":[{"name":"Health Research Union (HRU), Tbilisi, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgi","family":"Kanchelashvili","sequence":"additional","affiliation":[{"name":"Health Research Union (HRU), Tbilisi, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maia","family":"Butsashvili","sequence":"additional","affiliation":[{"name":"Health Research Union (HRU), Tbilisi, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"key":"2026111421180254000_15.11.e103983.1","unstructured":"UNAIDS, Global HIV & AIDS statistics . Fact sheet. 2024. Available: https:\/\/www.unaids.org\/en\/resources\/fact-sheet"},{"key":"2026111421180254000_15.11.e103983.2","unstructured":"WHO . HIV\/AIDS Key Facts, 2024. Available: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hiv-aids"},{"key":"2026111421180254000_15.11.e103983.3","unstructured":"In Danger: UNAIDS Global AIDS Update, 2022. Available: https:\/\/www.unaids.org\/en\/resources\/documents\/2022\/in-danger-global-aids-update"},{"key":"2026111421180254000_15.11.e103983.4","unstructured":"UNAIDS Data, 2023. Available: https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/data-book-2023_en.pdf"},{"key":"2026111421180254000_15.11.e103983.5","first-page":"103493","article-title":"Sexual transmission is a significant driver of HIV epidemics among people who inject drugs","volume":"100","author":"Dumchev","year":"2022","journal-title":"International Journal of Drug Policy"},{"key":"2026111421180254000_15.11.e103983.6","doi-asserted-by":"publisher","DOI":"10.1093\/jurban\/jtg007"},{"key":"2026111421180254000_15.11.e103983.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2009.02.008"},{"key":"2026111421180254000_15.11.e103983.8","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-012-0276-0"},{"key":"2026111421180254000_15.11.e103983.9","doi-asserted-by":"publisher","DOI":"10.1086\/318131"},{"key":"2026111421180254000_15.11.e103983.10","doi-asserted-by":"crossref","first-page":"105779","DOI":"10.1016\/j.ypmed.2019.105779","article-title":"Sexual risk behaviors and STDs among persons who inject drugs: A national study","volume":"126","author":"Brookmeyer","year":"2019","journal-title":"Prev Med"},{"key":"2026111421180254000_15.11.e103983.11","doi-asserted-by":"publisher","DOI":"10.1136\/sti.75.1.3"},{"key":"2026111421180254000_15.11.e103983.12","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1097\/01.aids.0000390704.35642.47","article-title":"Treatment of sexually transmitted infections for HIV prevention: end of the road or new beginning?","volume":"24 Suppl 4","author":"Hayes","year":"2010","journal-title":"AIDS"},{"key":"2026111421180254000_15.11.e103983.13","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1177\/003335491412900210","article-title":"Extremely High Risk for HIV following a diagnosis of syphilis, men living in Florida, 2000-2011","volume":"129","author":"Peterman","year":"2014","journal-title":"Pub Health Rep"},{"key":"2026111421180254000_15.11.e103983.14","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit437"},{"key":"2026111421180254000_15.11.e103983.15","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25355","article-title":"Sexually transmitted infections and HIV in the era of antiretroviral treatment and prevention: the biologic basis for epidemiologic synergy","volume":"22 Suppl 6","author":"Cohen","year":"2019","journal-title":"J Int AIDS Soc"},{"key":"2026111421180254000_15.11.e103983.16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0140-6736(98)90002-2","article-title":"Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis","volume":"351 Suppl 3","author":"Cohen","year":"1998","journal-title":"Lancet"},{"key":"2026111421180254000_15.11.e103983.17","unstructured":"UNAIDS . Country Progress Report \u2013 Georgia. Global AIDS Monitoring, 2020. Available: https:\/\/www.unaids.org\/sites\/default\/files\/country\/documents\/GEO_2020_countryreport.pdf"},{"key":"2026111421180254000_15.11.e103983.18","doi-asserted-by":"crossref","first-page":"e1192","DOI":"10.1016\/S2214-109X(17)30375-3","article-title":"Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review","volume":"5","author":"Degenhardt","year":"2017","journal-title":"Lancet Glob Health"},{"key":"2026111421180254000_15.11.e103983.19","unstructured":"Population size estimation of PWID in Georgia . Study Report, 2022. Available: https:\/\/hru.ge\/en\/projects\/6-aiv_shidsis-gavrtselebis-mkhriv-magali-riskis-qtsevis-mqone-jgupshi-narkotikebis-ineqtsiuri-gzit-momkhmareblebis-sarisko-qtsevebis-da-populatsiis-raodenobis-gansazgvra"},{"key":"2026111421180254000_15.11.e103983.20","unstructured":"Infectious Diseases, AIDS and Clinical Immunology Research Center . HIV\/AIDS Epidemiology in Georgia, Available: https:\/\/www.aidscenter.ge\/epidsituation_eng.html"},{"key":"2026111421180254000_15.11.e103983.21","first-page":"257","article-title":"Barriers to treatment access for women who use drugs in Georgia","volume":"45","author":"Otiashvili","year":"2013","journal-title":"J Subst Abuse Treat"},{"key":"2026111421180254000_15.11.e103983.22","first-page":"333","article-title":"Women who inject drugs in Georgia: Invisibility, double stigma and structural violence","volume":"20","author":"Chikovani","year":"2013","journal-title":"Drugs Educ Prev Policy"},{"key":"2026111421180254000_15.11.e103983.23","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.drugpo.2013.05.004","article-title":"Access to treatment for substance-using women in the Republic of Georgia: socio-cultural and structural barriers","volume":"24","author":"Otiashvili","year":"2013","journal-title":"Int J Drug Policy"},{"key":"2026111421180254000_15.11.e103983.24","unstructured":"National Centers for Disease Control and Public Health of Georgia . Statistical reference book of healthcare, 2021. Available: https:\/\/test.ncdc.ge\/pages\/user\/News.aspx?ID=ea1784b5-d3d0-4dd9-b29f-1369f5d6bbec"},{"key":"2026111421180254000_15.11.e103983.25","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2020-054706"},{"key":"2026111421180254000_15.11.e103983.26","doi-asserted-by":"crossref","first-page":"447","DOI":"10.4103\/0971-5916.198665","article-title":"A single weighting approach to analyze respondent-driven sampling data","volume":"144","author":"Selvaraj","year":"2016","journal-title":"Indian J Med Res"},{"key":"2026111421180254000_15.11.e103983.27","doi-asserted-by":"publisher","DOI":"10.1111\/j.0081-1750.2004.00152.x"},{"key":"2026111421180254000_15.11.e103983.28","first-page":"79","article-title":"Probability based estimation theory for respondent-driven sampling","volume":"24","author":"Volz","year":"2008","journal-title":"J Off Stat"},{"key":"2026111421180254000_15.11.e103983.29","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/aje\/kwx208","article-title":"Identification of Homophily and Preferential Recruitment in Respondent-Driven Sampling","volume":"187","author":"Crawford","year":"2018","journal-title":"Am J Epidemiol"},{"key":"2026111421180254000_15.11.e103983.30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-9531.2010.01223.x"},{"key":"2026111421180254000_15.11.e103983.31","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/EDE.0b013e31823ac17c","article-title":"Evaluation of respondent-driven sampling","volume":"23","author":"McCreesh","year":"2012","journal-title":"Epidemiology (Sunnyvale)"},{"key":"2026111421180254000_15.11.e103983.32","doi-asserted-by":"crossref","first-page":"772","DOI":"10.3855\/jidc.9103","article-title":"Human immunodeficiency virus prevalence and risk determinants among people who inject drugs in the Republic of Georgia","volume":"11","author":"Shengelia","year":"2017","journal-title":"J Infect Dev Ctries"},{"key":"2026111421180254000_15.11.e103983.33","unstructured":"Curatio International Foundation . HIV risk and prevention behaviors among people who inject drugs - integrated bio-behavioral surveillance survey in seven cities of georgia. study report. 2017. Available: https:\/\/curatiofoundation.org\/wp-content\/uploads\/2018\/02\/PWID-IBBS-Report-2017-ENG.pdf"},{"key":"2026111421180254000_15.11.e103983.34","unstructured":"UNAIDS epidemiological estimates . Regional Fact Sheet. Eastern Europe and central Asia, 2023. Available: https:\/\/thepath.unaids.org\/wp-content\/themes\/unaids2023\/assets\/files\/regional_fs_eastern_europe_central_asia.pdf"},{"key":"2026111421180254000_15.11.e103983.35","unstructured":"National Center for Infectious Diseases of Armenia . Integrated bio-behavioral surveillance surveys and key population size estimations among people who inject drugs, female sex workers, men who have sex with men and transgender persons. 2021. Available: https:\/\/ncid.am\/uploads\/shared-files\/Armenia_IBBS-2021_ENG.pdf"},{"key":"2026111421180254000_15.11.e103983.36","unstructured":"UNAIDS data, 2019. Available: https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/2019-UNAIDS-data_en.pdf"},{"key":"2026111421180254000_15.11.e103983.37","doi-asserted-by":"crossref","first-page":"104319","DOI":"10.1016\/j.drugpo.2024.104319","article-title":"Integrated biobehavioral surveillance among people who inject drugs in Ukraine, 2007-2020","volume":"144","author":"Dumchev","year":"2025","journal-title":"Int J Drug Policy"},{"key":"2026111421180254000_15.11.e103983.38","doi-asserted-by":"crossref","first-page":"10","DOI":"10.36233\/0372-9311-2018-6-10-18","article-title":"HIV PREVALENCE AMONG VULNERABLE GROUPS IN RUSSIA - RESULTS OF AN INTEGRATED BIO-BEHAVIORAL SURVEY","volume":"95","author":"Plavinskiy","year":"2018","journal-title":"Journal of Microbiology, Epidemiology and Immunobiology"},{"key":"2026111421180254000_15.11.e103983.39","unstructured":"Larney S . A global picture of injecting drug use, hiv and anti-hcv prevalence among people who inject drugs, and coverage of harm reduction interventions. Drug and Alcohol Connections; 2017. Available: https:\/\/www.connections.edu.au\/researchfocus\/global-picture-injecting-drug-use-hiv-and-anti-hcv-prevalence-among-people-who-inject"},{"key":"2026111421180254000_15.11.e103983.40","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-001465","article-title":"HIV among people who inject drugs in Central and Eastern Europe and Central Asia: a systematic review with implications for policy","volume":"2","author":"Jolley","year":"2012","journal-title":"BMJ Open"},{"key":"2026111421180254000_15.11.e103983.41","doi-asserted-by":"crossref","DOI":"10.1093\/eurpub\/ckac131.200","article-title":"Prevalence of hepatitis B and C, HIV, and syphilis among people who inject drugs in Germany","volume":"32","author":"Steffen","year":"2022","journal-title":"Eur J Public Health"},{"key":"2026111421180254000_15.11.e103983.42","doi-asserted-by":"crossref","first-page":"13","DOI":"10.21101\/cejph.a6937","article-title":"Analysis of drug-related infectious diseases in people who inject drugs - Pilsen Region, 2003-2018","volume":"30","author":"Sekera","year":"2022","journal-title":"Cent Eur J Public Health"},{"key":"2026111421180254000_15.11.e103983.43","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1080\/09540121.2020.1856320","article-title":"Trends of HIV, hepatitis C virus and syphilis seroprevalence among injection and non-injection drug users in southwestern China, 2010-2017","volume":"36","author":"Jiang","year":"2024","journal-title":"AIDS Care"},{"key":"2026111421180254000_15.11.e103983.44","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1177\/0956462420929132","article-title":"Syphilis infection among people who use and inject drugs in Cambodia: a cross-sectional study using the respondent-driven sampling method","volume":"31","author":"Yi","year":"2020","journal-title":"Int J STD AIDS"},{"key":"2026111421180254000_15.11.e103983.45","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1080\/20477724.2023.2191234","article-title":"Risk factors of HIV and variation in access to clean needles among people who inject drugs in Pakistan","volume":"117","author":"Capelastegui","year":"2023","journal-title":"Pathog Glob Health"},{"key":"2026111421180254000_15.11.e103983.46","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-022-13922-2","article-title":"HIV among people who inject drugs in India: a systematic review","volume":"22","author":"Pachuau","year":"2022","journal-title":"BMC Public Health"},{"key":"2026111421180254000_15.11.e103983.47","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph20105871","article-title":"Changes in and Predictors of HIV among People Who Inject Drugs in Mizoram, Northeast India, from 2007 to 2021","volume":"20","author":"Pachuau","year":"2023","journal-title":"Int J Environ Res Public Health"},{"key":"2026111421180254000_15.11.e103983.48","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1007\/s10461-022-03627-3","article-title":"HIV Prevalence and Related Behaviors Among People Who Inject Drugs in Iran from 2010 to 2020","volume":"26","author":"Khezri","year":"2022","journal-title":"AIDS Behav"},{"key":"2026111421180254000_15.11.e103983.49","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2021.26.49.2002093","article-title":"Univariable associations between a history of incarceration and HIV and HCV prevalence among people who inject drugs across 17 countries in Europe 2006 to 2020 - is the precautionary principle applicable?","volume":"26","author":"Wiessing","year":"2021","journal-title":"Euro Surveill"},{"key":"2026111421180254000_15.11.e103983.50","doi-asserted-by":"publisher","DOI":"10.1177\/0956462414568394"},{"key":"2026111421180254000_15.11.e103983.51","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/QCO.0000000000000801","article-title":"Challenges of sexually transmitted infections and sexual health among people who inject drugs","volume":"35","author":"Dumchev","year":"2022","journal-title":"Curr Opin Infect Dis"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-103983","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T05:21:18Z","timestamp":1794720078000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-103983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":51,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11,24]]},"published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10.1136\/bmjopen-2025-103983"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-103983","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1136\/bmjopen-2025-103983.supp1","asserted-by":"subject"}]},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11]]}}}